SHC
Research Snapshot
Static fundamentals, valuation context, and investor signals for Sotera Health Co (SHC).
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
2.8%
ROIC, 12.8% FCF margin
Growth
7.3%
5Y sales (revenue) CAGR
Balance sheet
3.5x
Debt/equity, 2.5x current ratio
Superinvestors
1
Top: David Einhorn (0.9%)
Strengths to research
- Free cash flow compounded at 17.3% over five years.
- Free cash flow margin is healthy at 12.8%.
Watchouts
- Debt/equity is high at 3.5x.
- Valuation multiples are limited or unavailable.
Annual data: 7 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for SHC.
Grade F
23
/ 100
Financial Charts
No financial data available for SHC (annual).
1 superinvestors own SHC
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| David Einhorn Greenlight Capital | 2,065,680 | $30M | 0.93% | ▲ +15.7% |